R&D

We contribute to promoting human health.
We are the global leader in stem cell therapies

  • HOME
  • R&D
  • Patents and Research Papers

PATENTS

  • Name of invention

    Novel thiazolidinedione derivatives and uses thereof

    Registration date

    2012.08.02

    Registration and application number

    No. 10-1172638

    Summary

    Since it exhibits the activity of inhibiting 15-PGDH that breaks down prostaglandin, it can be effectively used to prevent or treat cardiovascular diseases, gastrointestinal diseases, and kidney diseases, and can be effectively used to prevent hair loss and promote hair growth.

  • Name of invention

    COMPOSITION COMPRISING CELLS TREATED WITH 15-PGDH INHIBITOR OR CULTURE THEREOF AND USE THEREOF

    Registration date

    2016.10.27

    Registration and application number

    No. 15771853

  • Name of invention

    Liposuction and SVF separation kit

    Registration date

    2017.09.21

    Registration and application number

    No. 10-1782386

    Summary

    To facilitate the process of collecting fat and a series of processes for separating stem cells to obtain adipose-derived stem cells

  • Name of invention

    Compositions and uses comprising cells treated with 15-PGDH inhibitors or cultures thereof

    Registration date

    2018.03.16

    Registration and application number

    No. 10-1843927

    Summary

    A pharmaceutical composition for the prevention or treatment of atopic diseases comprising cells cultured by adding a 15-PGDH inhibitor to cells expressing PGE2 or a culture thereof (atopic dermatitis)

  • Name of invention

    Compositions and uses comprising cells treated with 15-PGDH inhibitors or cultures thereof

    Registration date

    2018.03.26

    Registration and application number

    No. 10-1843927

    Summary

    A pharmaceutical composition for the prevention or treatment of atopic diseases comprising cells cultured by adding a 15-PGDH inhibitor to cells expressing PGE2 or a culture thereof (atopic dermatitis)

  • Name of invention

    Compositions and uses comprising cells treated with 15-PGDH inhibitors or cultures thereof

    Registration date

    2018.10.22

    Registration and application number

    No. 10-1912142

    Summary

    A pharmaceutical composition for the prevention or treatment of atopic diseases comprising cells cultured by adding a 15-PGDH inhibitor to cells expressing PGE2 or a culture thereof (Rheumatoid arthritis)

  • Name of invention

    Method for mass culturing fat-derived stem cells expressing FoxO

    Registration date

    2018.12.28

    Summary

    Composition comprising cells treated with 15-PGDH inhibitor or culture therof and use therof

  • Name of invention

    Medium composition for culturing urine-derived stem cells and method for culturing urine-derived stem cells using the same

    Registration date

    2019.11.04

    Summary

    A culture medium for isolation of urine-derived stem cells, a culture medium for culturing urine-derived stem cells, and a method for separating and culturing urine-derived stem cells using the culture medium

  • Name of invention

    Mass culture method of adipose-derived stem cells expressing anti-aging factors

    Registration date

    2020.02.03

    Summary

    Mass culture method of adipose-derived stem cells expressing anti-aging factors (Foxo1, Foxo3a and Klotho) and medium composition for proliferation and culture of adipose-derived stem cells

  • Name of invention

    A composition for skin regeneration, whitening, antioxidant or wound treatment comprising stem cell-derived exosomes as an active ingredient, and uses thereof

    Registration date

    2021.02.17

    Summary

    A cosmetic composition or pharmaceutical composition for skin regeneration, whitening, antioxidant or wound treatment comprising urine-derived stem cell-derived exosomes as an active ingredient

  • Name of invention

    A medium composition for culturing urine-derived stem cells, a method for separating and culturing urine-derived stem cells using the same, urinary-derived stem cells with improved renal disease treatment function, and a cell therapeutic composition comprising the same

    Registration date

    2021.09.29

    Summary

    A culture medium for isolation and culturing of urine-derived stem cells, a method for separating and culturing urine-derived stem cells using the culture medium, urine-derived stem cells cultured in the culture medium, and a cell therapeutic composition comprising the same

CERTIFICATE

  • EHLBio Research Institute Certification

  • European EHLBio trademark

  • Indonesia EHLBio Trademark Rights

  • 키셀 trademark registration certificate

  • Kissel trademark registration certificate

RESEARCH PAPERS

  • Name

    Human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis via regulation of B lymphocyte maturation

    date

    2016.06.06

  • Name

    Human Adipose Tissue-Derived Mesenchymal Stem Cells Attenuate Atopic Dermatitis by Regulating the Expression of MIP-2, miR-122a-SOCS1 Axis, and Th1/Th2 Responses

    Date

    2018.11.06

  • Name

    Urine-Derived Stem Cell-Secreted Klotho Plays a Crucial Role in the HK-2 Fibrosis Model by Inhibiting the TGF-β Signaling Pathway

    Date

    2022. 4.30